150 Results for “William Lazonick”

The $48 Billion Stock-Option Package and its Implications for the EV Transition

The Institute for New Economic Thinking has awarded $2 million in grants to fund 21 different projects as part of the latest round of its research grant program.

Contrary to pharmaceutical company claims, revenue from high insulin prices are going to shareholders, not R&D

Author Rana Foroohar explains why the economic policies being touted by both presidential frontrunners offer none of the new thinking necessary to drive a policy response to revitalize the economy

Why are we paying for corporate behavior that crushes innovation, cheats taxpayers, cost jobs, and heightens inequality?

Doctors and medical experts say private equity firms and profiteering corporations are putting American lives at risk and compromising the practice of medicine.

Medicare Needs a Perspective on “Collective and Cumulative Learning” in Inflation Reduction Act Negotiations

How Penrosian Learning Confronts the Neoclassical Fallacy

Notes from the Institute’s Director of Research on some significant papers and contributions produced in 2016 under the INET rubric 

There is much for U.S. authorities to learn from the European example of forcing corporations to pay their fair share of taxes, but more far-reaching oversight of executives’ allocation of resources is also required

US regulators can step in to ensure drug pricing both supports patient access and drug development

Research funded by the Institute for New Economic Thinking has revealed that the SEC reports executive compensation using a formula that routinely undercounts it

New approaches are being developed, but efforts are fragmented and need to be brought together if we hope to piece together a paradigm. 

From the perspective of innovative enterprise, we ask how Musk might abuse his power of strategic control—and what that would mean for corporate governance reform.

To fulfill MLK’s vision of jobs and freedom for Black Americans, Washington must rein in corporate greed